Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $321K | +11.7K | +118.43% | $27.34 | 21.7K | Feb 23, 2022 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$110K | -2.34K | -10.79% | $46.87 | 19.3K | Feb 23, 2022 | Direct | F2 |
transaction | PFE | Common Stock | Tax liability | -$298K | -5.82K | -30.08% | $51.28 | 13.5K | Feb 23, 2022 | Direct | F3, F4 |
transaction | PFE | Common Stock | Award | $0 | +2.89K | +21.41% | $0.00 | 16.4K | Feb 24, 2022 | Direct | F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -11.7K | -100% | $0.00* | 0 | Feb 23, 2022 | Common Stock | 11.7K | $27.34 | Direct | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +11.6K | $0.00 | 11.6K | Feb 24, 2022 | Common Stock | 11.6K | $45.96 | Direct | F6 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +10.2K | $0.00 | 10.2K | Feb 24, 2022 | Common Stock | 10.2K | $45.96 | Direct | F7 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F5 | The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. |
F6 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F7 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |